CYP3A5
E905090
CYP3A5 is a liver-expressed cytochrome P450 enzyme that metabolizes various drugs and xenobiotics, contributing to interindividual variability in drug clearance.
Statements (56)
| Predicate | Object |
|---|---|
| instanceOf |
cytochrome P450 enzyme
ⓘ
drug-metabolizing enzyme ⓘ enzyme ⓘ protein ⓘ |
| affects |
calcineurin inhibitor pharmacokinetics
ⓘ
tacrolimus dose requirements ⓘ |
| alleleCYP3A5*1 | expressor allele ⓘ |
| alleleCYP3A5*3 | non-expressor allele ⓘ |
| alleleCYP3A5*6 | non-functional allele ⓘ |
| alleleCYP3A5*7 | non-functional allele ⓘ |
| contributesTo |
first-pass metabolism of orally administered drugs
ⓘ
interindividual variability in drug clearance ⓘ |
| encodedBy | CYP3A5 gene NERFINISHED ⓘ |
| foundInTaxon | Homo sapiens NERFINISHED ⓘ |
| hasAllele |
CYP3A5*1
ⓘ
CYP3A5*3 NERFINISHED ⓘ CYP3A5*6 NERFINISHED ⓘ CYP3A5*7 NERFINISHED ⓘ |
| hasBiologicalProcess |
drug metabolic process
ⓘ
oxidation-reduction process ⓘ steroid metabolic process ⓘ xenobiotic metabolic process ⓘ |
| hasCofactor | heme ⓘ |
| hasMolecularFunction |
drug binding
ⓘ
monooxygenase activity ⓘ oxidoreductase activity ⓘ |
| highlyExpressedIn | CYP3A5*1 carriers ⓘ |
| inducedBy |
carbamazepine
NERFINISHED
ⓘ
rifampin NERFINISHED ⓘ |
| inhibitedBy |
azole antifungals
ⓘ
macrolide antibiotics ⓘ |
| isClinicallyRelevantFor | pharmacogenomics ⓘ |
| isPolymorphic | true ⓘ |
| locatedIn |
adrenal gland
ⓘ
endoplasmic reticulum membrane ⓘ intestine ⓘ kidney ⓘ liver ⓘ |
| lowOrAbsentExpressionIn | CYP3A5*3 homozygotes ⓘ |
| memberOf |
CYP3A subfamily
NERFINISHED
ⓘ
cytochrome P450 superfamily NERFINISHED ⓘ |
| metabolizes |
carbamazepine
ⓘ
cyclosporine ⓘ endogenous steroids ⓘ midazolam NERFINISHED ⓘ nifedipine NERFINISHED ⓘ protease inhibitors ⓘ statins ⓘ tacrolimus ⓘ |
| orthologInHuman | CYP3A5 NERFINISHED ⓘ |
| regulatedBy |
constitutive androstane receptor
NERFINISHED
ⓘ
pregnane X receptor NERFINISHED ⓘ |
| requires |
NADPH
ⓘ
cytochrome P450 reductase NERFINISHED ⓘ |
| subcellularLocation | microsome ⓘ |
| usesSubstrate | lipophilic compounds ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Docetaxel